Aadi Bioscience, Inc. (ARPO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total revenue	15.2	1.1	14.6		20.2
Total revenue growth	1258.6%	-92.3%		-100.0%
Operating expenses
Selling, general and administrative	40.2
Research and development	32.7	19.7	15.0	12.8	17.9	12.1	11.4
Impairment of acquired contract intangible asset		74.2
Total operating expenses	79.2
Loss from operations	-62.7	-111.2	-2.5	-24.4	-11.2	-21.4	-16.6	0.0
Operating margin	-411.9%	-9930.1%	-17.5%		-55.5%

Other income (expense)
Interest income	2.4	0.0	0.0
Interest expense		-0.7	-0.8			-0.1	-0.5	0.0
Total other income (expense), net		1.1	-0.9				0.0
Loss before income tax expense		-110.1	-3.5
Income tax expense		0.0	0.0
Net loss	-60.5	-110.1	-3.5	-23.3	-10.4	-21.4	-17.0	0.0

Other comprehensive loss:
Comprehensive loss	-60.6	-110.7	-4.5

Net loss per share, basic (in dollars per share)	($2.69)	($12.41)	($1.76)	($0.57)	($0.31)	($1.03)	($24.52)	($0.01)
Net loss per share, diluted (in dollars per share)	($2.69)	($12.41)	($1.76)	($0.57)	($0.31)	($1.03)	($24.52)	($0.01)

Weighted-average number of common shares outstanding, basic (in shares)	22.5	8.9	2.5	40.6	33.9	21.7	0.9	5.0
Weighted-average number of common shares outstanding, diluted (in shares)	22.5	8.9	2.5	40.6	33.9	21.7	0.9	5.0